US0109111056
US0109111056
Alamar Biosciences, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 74.211.000 | 25.142.000 | 195.2% |
| Cost of Revenue | 32.506.000 | 16.535.000 | 96.6% |
| Gross Profit | 41.705.000 | 8.607.000 | 384.5% |
| 73.039.000 | 58.175.000 | 25.6% | |
| Operating Income | -31.334.000 | -49.568.000 | 36.8% |
| Pretax Income | -29.154.000 | -47.060.000 | 38.0% |
| Net Income Common Stockholders | -29.819.000 | -47.073.000 | 36.7% |
| -- | -- | -- | |
| -- | -- | -- |